Occurrence of a Ki-1-positive anaplastic large-cell lymphoma in a patient with Ph′ positive chronic myelogenous leukemia successfully treated by alpha-interferon

Enrico Montefusco, Francesco Lo Coco, Vito Lelio Burgio, Beatrice Rondinelli, Giulia Di Giorgio, Marco Mancini, Daniela Diverio, Alessandro Andriani, Giuseppe Avvisati, Giuliana Alimena

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We describe a patient with Philadelphia-chromosome-positive (Ph′ +) chronic myelogenous leukemia (CML), who developed an anaplastic large cell lymphoma (ALCL) with T-phenotype, after 43 months successful treatment with alpha-interferon (IFN). Characterization studies of lymphoma cells showed positivity for Ki-1 monoclonal antibody, T-cell surface markers, T-cell receptor beta chain rearrangement, and germline configuration of the BCR gene. At the time of lymphoma diagnosis, the patient had achieved complete hematologic remission from CML with partial karyotypic conversion (50% Ph′ + cells). After twelve weekly courses of polychemotherapy, he obtained complete remission from lymphoma. At present, five years from CML diagnosis, the patient has a remarkably stable disease, being in remission from lymphoma and in well controlled CML chronic phase. Our case thus represents the first well documented description of a T-cell non-Hodgkin's lymphoma developed during the course of CML.

Original languageEnglish
Pages (from-to)1896-1899
Number of pages4
JournalLeukemia
Volume7
Issue number11
Publication statusPublished - Nov 1993

Fingerprint

Anaplastic Large-Cell Lymphoma
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Interferon-alpha
Lymphoma
Leukemia, Myeloid, Chronic Phase
Antigen Receptors, T-Cell, alpha-beta
Philadelphia Chromosome
T-Cell Lymphoma
Combination Drug Therapy
Non-Hodgkin's Lymphoma
Monoclonal Antibodies
T-Lymphocytes
Phenotype
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Occurrence of a Ki-1-positive anaplastic large-cell lymphoma in a patient with Ph′ positive chronic myelogenous leukemia successfully treated by alpha-interferon. / Montefusco, Enrico; Lo Coco, Francesco; Burgio, Vito Lelio; Rondinelli, Beatrice; Di Giorgio, Giulia; Mancini, Marco; Diverio, Daniela; Andriani, Alessandro; Avvisati, Giuseppe; Alimena, Giuliana.

In: Leukemia, Vol. 7, No. 11, 11.1993, p. 1896-1899.

Research output: Contribution to journalArticle

Montefusco, E, Lo Coco, F, Burgio, VL, Rondinelli, B, Di Giorgio, G, Mancini, M, Diverio, D, Andriani, A, Avvisati, G & Alimena, G 1993, 'Occurrence of a Ki-1-positive anaplastic large-cell lymphoma in a patient with Ph′ positive chronic myelogenous leukemia successfully treated by alpha-interferon', Leukemia, vol. 7, no. 11, pp. 1896-1899.
Montefusco, Enrico ; Lo Coco, Francesco ; Burgio, Vito Lelio ; Rondinelli, Beatrice ; Di Giorgio, Giulia ; Mancini, Marco ; Diverio, Daniela ; Andriani, Alessandro ; Avvisati, Giuseppe ; Alimena, Giuliana. / Occurrence of a Ki-1-positive anaplastic large-cell lymphoma in a patient with Ph′ positive chronic myelogenous leukemia successfully treated by alpha-interferon. In: Leukemia. 1993 ; Vol. 7, No. 11. pp. 1896-1899.
@article{5be019e5b9714327b2e106f309e97200,
title = "Occurrence of a Ki-1-positive anaplastic large-cell lymphoma in a patient with Ph′ positive chronic myelogenous leukemia successfully treated by alpha-interferon",
abstract = "We describe a patient with Philadelphia-chromosome-positive (Ph′ +) chronic myelogenous leukemia (CML), who developed an anaplastic large cell lymphoma (ALCL) with T-phenotype, after 43 months successful treatment with alpha-interferon (IFN). Characterization studies of lymphoma cells showed positivity for Ki-1 monoclonal antibody, T-cell surface markers, T-cell receptor beta chain rearrangement, and germline configuration of the BCR gene. At the time of lymphoma diagnosis, the patient had achieved complete hematologic remission from CML with partial karyotypic conversion (50{\%} Ph′ + cells). After twelve weekly courses of polychemotherapy, he obtained complete remission from lymphoma. At present, five years from CML diagnosis, the patient has a remarkably stable disease, being in remission from lymphoma and in well controlled CML chronic phase. Our case thus represents the first well documented description of a T-cell non-Hodgkin's lymphoma developed during the course of CML.",
author = "Enrico Montefusco and {Lo Coco}, Francesco and Burgio, {Vito Lelio} and Beatrice Rondinelli and {Di Giorgio}, Giulia and Marco Mancini and Daniela Diverio and Alessandro Andriani and Giuseppe Avvisati and Giuliana Alimena",
year = "1993",
month = "11",
language = "English",
volume = "7",
pages = "1896--1899",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Occurrence of a Ki-1-positive anaplastic large-cell lymphoma in a patient with Ph′ positive chronic myelogenous leukemia successfully treated by alpha-interferon

AU - Montefusco, Enrico

AU - Lo Coco, Francesco

AU - Burgio, Vito Lelio

AU - Rondinelli, Beatrice

AU - Di Giorgio, Giulia

AU - Mancini, Marco

AU - Diverio, Daniela

AU - Andriani, Alessandro

AU - Avvisati, Giuseppe

AU - Alimena, Giuliana

PY - 1993/11

Y1 - 1993/11

N2 - We describe a patient with Philadelphia-chromosome-positive (Ph′ +) chronic myelogenous leukemia (CML), who developed an anaplastic large cell lymphoma (ALCL) with T-phenotype, after 43 months successful treatment with alpha-interferon (IFN). Characterization studies of lymphoma cells showed positivity for Ki-1 monoclonal antibody, T-cell surface markers, T-cell receptor beta chain rearrangement, and germline configuration of the BCR gene. At the time of lymphoma diagnosis, the patient had achieved complete hematologic remission from CML with partial karyotypic conversion (50% Ph′ + cells). After twelve weekly courses of polychemotherapy, he obtained complete remission from lymphoma. At present, five years from CML diagnosis, the patient has a remarkably stable disease, being in remission from lymphoma and in well controlled CML chronic phase. Our case thus represents the first well documented description of a T-cell non-Hodgkin's lymphoma developed during the course of CML.

AB - We describe a patient with Philadelphia-chromosome-positive (Ph′ +) chronic myelogenous leukemia (CML), who developed an anaplastic large cell lymphoma (ALCL) with T-phenotype, after 43 months successful treatment with alpha-interferon (IFN). Characterization studies of lymphoma cells showed positivity for Ki-1 monoclonal antibody, T-cell surface markers, T-cell receptor beta chain rearrangement, and germline configuration of the BCR gene. At the time of lymphoma diagnosis, the patient had achieved complete hematologic remission from CML with partial karyotypic conversion (50% Ph′ + cells). After twelve weekly courses of polychemotherapy, he obtained complete remission from lymphoma. At present, five years from CML diagnosis, the patient has a remarkably stable disease, being in remission from lymphoma and in well controlled CML chronic phase. Our case thus represents the first well documented description of a T-cell non-Hodgkin's lymphoma developed during the course of CML.

UR - http://www.scopus.com/inward/record.url?scp=0027484635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027484635&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 1896

EP - 1899

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 11

ER -